9109-0126 Quebec Inc.

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Type 2 diabetes4 trials
• Obesity2 trials
• Chronic kidney disease1 trial

Phase

• Phase 22 trials
• Phase 32 trials
• Phase 41 trial

Status

• Completed3 trials
• Active, not recruiting2 trials

Lead sponsor

• Eli Lilly and Company4 trials
• Inversago Pharma Inc.1 trial

Running trials

• Active, not recruiting

  Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)

  NCT06260722· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes

  NCT05433584· Phase 4· Eli Lilly and Company· Source

Closed trials

• Completed

  Study of INV-202 in Patients With Obesity and Metabolic Syndrome

  NCT05891834· Phase 2· Inversago Pharma Inc.· Source

• Completed

  A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

  NCT05936151· Phase 2· Eli Lilly and Company· Source

• Completed

  A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time

  NCT05362058· Phase 3· Eli Lilly and Company· Source